glp-1 weight loss timeline A of GLP- 1 discovery and clinical development. Created in GLP-1 Weight-Loss Drugs Ride Health,

While generally harmless and temporary, it can also be annoying and disruptive

Protein aggregation -Synuclein aggregation is a hallmark of PD, forming Lewy bodies that contribute to neuronal death, particularly in dopaminergic neurons in the substantia nigra

Bottom line Its up to you and your provider to decide how long you should stay on GLP-1 medications, and at what dose, to achieve and maintain sustainable weight loss

Historically, anti-obesity drugs have shown a lot of negative side effects and only moderate efficacy

Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials